Bluejay Diagnostics (BJDX) Current Assets (2020 - 2026)

Bluejay Diagnostics (BJDX) has 7 years of Current Assets data on file, last reported at $4.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 11.07% year-over-year to $4.0 million; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (up 11.07% YoY), and the FY2025 full-year result was $5.5 million, up 11.53% from the prior year.
• Current Assets fell to $4.0 million in Q1 2026, from $5.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $19.3 million in Q1 2022 to a low of $3.2 million in Q4 2023.
• A 5-year average of $7.8 million and a median of $6.5 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 326.99% in 2022 and plunged 72.68% in 2023, its largest moves.
• Tracing BJDX's Current Assets over 5 years: stood at $11.8 million in 2022, then sank by 72.68% to $3.2 million in 2023, then surged by 52.1% to $4.9 million in 2024, then advanced by 11.53% to $5.5 million in 2025, then retreated by 27.38% to $4.0 million in 2026.
• Business Quant data shows BJDX's Current Assets at $4.0 million in Q1 2026, $5.5 million in Q4 2025, and $3.4 million in Q3 2025.